The purpose of this study was to determine the effects of homocysteine, which consumes intracellu lar adenosine via formation of S-adenosylhomocysteine, on interstitial fluid (ISF) adeonsine and cerebral blood flow (CBF) before, during, and after cerebral ischemia. Microdialysis probes, used to measure local CBF (H2 clearance) and to sample ISF, were implanted bilaterally into the caudate nucleus of halothane-anesthetized rats (n = 8). L-Homocysteine thiolactone was administered lo cally via one of the probes. Animals were exposed to 20 min of ischemia, induced by bilateral carotid occlusion plus hemorrhage to an arterial blood pressure of 50 mm Hg, followed by 60 min of reperfusion. Before ischemia, Abbreviations used: ISF, interstitial fluid; SAH, S-adenosyl homocysteine.
During cerebral ischemia, interstitial fluid (ISF) adenosine accumulates as ATP is rapidly depleted (Berne et aI., 1974; Van Wylen et aI., 1986; Hillered et aI., 1989; Sciotti et aI., 1992) . Elevations in aden osine may play a role in the vasodilation that is observed following transient global cerebral isch emia (Regli et aI., 1971; Seida et aI., 1988; Meno et al., 1991) and in the attenuation of excitatory amino acid neurotransmitter release during and after cere bral ischemia (Andine et aI., 1990; Sciotti et aI., 1992) .
One route of adenosine metabolism is through condensation with homocysteine to form S-adeno sylhomocysteine (SAH). The enzyme responsible for this reaction, SAH-hydrolase, is widely distrib uted within cells throughout the central nervous system (Schatz et aI., 1977; Broch and Ueland, 1980; Gharib et aI., 1983) . Despite the presence of SAH-hydrolase, conditions that lead to increased cerebral or myocardial adenosine do not result in increased SAH levels (Schrader et aI., 1981; Red dington and Pusch, 1983) . The limited incorporation of adenosine into SAH suggests that L-homocys teine is rate limiting under conditions of adenosine excess. Provision of exogenous homocysteine would therefore be expected to enhance SAH for mation and thereby diminish free intra-and extra cellular adenosine. It was our intention to use the brain microdialysis technique to determine the ef fects of local homocysteine infusion on CBF and ISF adenosine, inosine, and hypoxanthine under basal conditions and during and after cerebral isch emia.
METHODS

Animal preparation
All experiments were performed on adult male Wistar rats (300-500 g). Animals were anesthetized initially with sodium thiamylal (50 mg/kg), after which a tracheostomy was performed and the animals mechanically ventilated with a mixture of oxygen, nitrogen, and 1.5-2.0% halo thane. Core body temperature was monitored with a rec tal temperature probe and maintained with a heating pad between 37°C and 38°C. The left femoral artery was can nulated for the measurement of arterial blood pressure (Statham model P23Db pressure transducer, Gould 2400 recorder, Greenbelt, MD, U.S.A.) and the withdrawal of arterial blood samples. The right femoral artery was can nulated for hemorrhage during cerebral ischemia. Both common carotid arteries were then exposed. Silk sutures were placed around each artery and passed through poly ethylene tubing to form snare ligatures.
In all animals, brain dialysate samples were collected bilaterally from the caudate nuclei. The details of the brain microdialysis technique as utilized by our labora tory have been published previously (Van Wylen et aI., 1986 . In preparation for implantation of the microdialysis probes into the brain, the animals were placed in a stereotaxic apparatus and the frontal and pa rietal bones of the skull exposed. Burr holes were then made bilaterally 0.5 mm anterior and 2.5 mm lateral to the bregma and each of the microdialysis probes (Clirans TH 10, Teruma Corp., Tokyo, Japan; inner diameter 300 /-lm; molecular weight cutoff 5,000 daltons) was lowered 8 mm below the dura such that a 5-mm length of dialysis fiber between the ends of the two silica tubes rested primarily in the caudate nucleus (Pelligrino et aI., 1979) . Once im planted in the brain, microdialysis probes were perfused with artificial cerebrospinal fluid (CSF) (NaCl 132.8 mM. NaHC0 3 24.6 mM. urea 6.7 mM. glucose 3.7 mM. KCl 3.0 mM. CaCl2 2.0 mM. and MgCl2 0.7 mM. bubbled with 95% N2-5% CO2) at a constant flow of 0.5 /-lllmin (Car negie Medicin AB model CMAloo microinjection pump, Lafayette, IN, U.S.A.).
CBF measurements
Local CBF was measured from the area surrounding the microdialysis probe by hydrogen clearance (Young, 1980) , using techniques previously described for local blood flow measurement in conjunction with brain mi crodialysis (Van Wylen et aI., 1988 . Hydrogen was introduced to the animal in the inspired air (7-10%) for approximately 2 min, after which the inspired hydrogen was turned off and the washout of hydrogen from the tissue was monitored. Local CBF was calculated from the time required for the hydrogen levels to fall from 90% maximum to 40% maximum using the formula:
.
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Protocol
Two groups of experiments were performed. For both groups, a 90-min period was allowed for recovery from microdialysis probe implantation, a time during which ISF purine levels have been shown to reach steady-state levels (Van Wylen et aI., 1986) .
Initial experiments (Group 1, n = 4) were performed to determine a dose response to L-homocysteine thiolactone (Sigma Chemical Co., St. Louis, MO, U.S.A.). Baseline measurements of CBF and collections of dialysate were made with both microdialysis probes being perfused with CSF. A microdialysis probe on one side of the brain was then perfused with CSF containing increasing concentra tions of homocysteine, while the contralateral probe con tinued to be perfused with CSF alone. The concentrations of homocysteine tested were 10-5 M. 10-4 M. and 10-3 M. Each solution was allowed to perfuse the probe for 10 min, after which time a 20-min dialysate sample was col lected and a blood flow measurement made.
The second set of experiments (Group 2, n = 8) was performed to determine the effects of infusion of 10 -3 M homocysteine on purine metabolite levels and the blood flow response to cerebral ischemia. Both microdialysis probes were initially perfused with CSF for 20 min. Dur ing this time, baseline dialysate samples were collected and CBF measurements made. The probe on one side of the brain was then perfused with CSF containing 10-3 M homocysteine, while the contralateral probe continued to be perfused with CSF alone. CBF measurements were made and 20-min dialysate samples collected during uni lateral homocysteine infusion before cerebral ischemia. Immediately before induction of ischemia, hydrogen was delivered to the animal. Reversible cerebral ischemia was then induced by bilateral carotid occlusion and arterial exsanguination to a blood pressure of 50 mm Hg. Hydro gen administration was then discontinued and a single CBF measurement made during ischemia. Two lO-min dialysate samples were collected during ischemia. Fol lowing 20 min of ischemia, the carotid snares were re moved. The shed blood was then slowly reinfused to re store blood pressure. Dialysate samples were collected and CBF determinations were made during a 60-min reperfusion period following ischemia.
Analytical procedures
Dialysate collected was analyzed for adenosine, ino sine, and hypoxanthine. The concentrations of metabo lites in the dialysate were determined by reverse phase HPLC (Waters, Division of Millipore, Milford, MA, U.S.A.) and ultraviolet detection at a wavelength of 254 nm (Waters Model 486 detector). Separation of the com pounds of interest was achieved using a 25-cm C18 col umn (Supelco, Bellefonte, PA, U.S.A.) and a methanol in 100 mM KH2P0 4 gradient [1% (pH 5.3) to 25% (pH 5.58)] at a flow rate of 1.3 mllmin. Under these conditions hy poxanthine, inosine, and adenosine were eluted at -5.8, 14.1, and 18.4 min, respectively. Identification of nucle osides was accomplished by comparing retention times and peak areas with those of external standards.
Statistical analysis
Mean values and standard deviations were calculated for all the data. Differences between mean values were determined using one of two types of statistical analyses: (a) paired t test for comparisons of dialysate concentra tions from the untreated side of the brain with those col lected at the same time from the treated side; (b) analysis of variance (ANOV A) followed by Dunnett's test for comparisons of dialysate concentrations for a given side to baseline. p < 0.05 was accepted as indication of a statistically significant difference.
RESULTS
The local infusion of homocysteine did not affect arterial blood pressure (103 ± 9 mm Hg), P02 (144 ± 29 mm Hg), Peo2 (39 ± 9 mm Hg), pH (7.39 ± 0.04), or heart rate (366 ± 62 beats/min) in Group 1 ani mals. Arterial P02 (147 ± 30 mm Hg), Peo2 (40 ± 6 mm Hg), pH (7.38 ± 0.04), and heart rate (355 ± 40 beats/min) were also stable throughout the isch-emiaireperfusion protocol in Group 2 animals. In Group 2 animals, arterial blood pressure increased transiently to 123 ± 9 mm Hg during early reperfu sion as a result of reinfusion of shed blood (baseline mean arterial pressure = 104 ± 8 mm Hg). In all animals, blood pressure returned to preischemia levels by 10 min of reperfusion.
The CBF and dialysate results for Group 1 exper iments are presented in Table 1 . On the control side of the brain, CBF and dialysate adenosine, inosine, and hypoxanthine did not change significantly throughout the protocol (data not shown). There was a dose-dependent decrease in dialysate adeno sine, inosine, and hypoxanthine with infusion of ho mocysteine. Dialysate adenosine levels were signif icantly attenuated at all concentrations of homocys teine tested. At 10-4 M and 10-3 M, homocysteine also significantly attenuated CBF.
Dialysate levels for Group 2 experiments are pre sented in Figs. 1-3. Baseline dialysate concentra tions (/-LM) on the untreated side were: adenosine = 0.49 ± 0.10, inosine = 0.87 ± 0.39, and hypoxan thine = 3.6 ± 1.8. On the side that was subse quently infused with homocysteine the baseline di alysate levels were (/-LM): adenosine = 0.37 ± 0.16, inosine = 0.8 ± 0.38, hypoxanthine = 2.9 ± 1. 2, (data not shown in figures). The addition of 10-3 M homocysteine to the dialysis probe before induction of ischemia resulted in significant decreases in dial ysate levels of adenosine, inosine, and hypoxanthine as compared with the untreated side ( Figs. 1-3) .
On the untreated side of the brain, ischemia re sulted in significant elevations of dialysate adeno sine, inosine, and hypoxanthine. Dialysate adeno sine increased � 10-fold during ischemia ( Fig. 1) and then returned to basal levels during reperfusion. Al though dialysate levels of inosine and hypoxanthine also increased during ischemia, the highest levels were observed in the reperfusion period ( Figs. 2  and 3) .
A similar pattern of purine metabolites during ischemia and reperfusion was observed on the side of locally infused homocysteine. However, dialy sate adenosine levels with homocysteine were sig nificantly attenuated when compared with dialysate levels observed during the same ischemic time pe riod on the untreated side of the brain (Fig. 1) . Throughout the reperfusion period, dialysate levels of adenosine were lower on the side of homocys teine infusion when compared with the untreated side of the brain. With the exception of the initial ischemia sample, dialysate inosine and hypoxan thine levels obtained with local homocysteine dur ing ischemia and reperfusion were not significantly different when compared with the control side (Fig. 2) . Figure 4 depicts local CBF responses to ischemia in the absence and presence of homocysteine. The addition of 10-3 M homocysteine to the CSF per fusing a probe resulted in a 23% decrease in resting local CBF. CBF levels of � 13 ml 100 g -1 min -1 were measured on both sides of the brain during 20 min of cerebral ischemia. Upon reperfusion, a sig nificant increase in CBF was observed on the side of the brain being perfused with CSF; however, the hyperemic response to ischemia was blunted on the side of homocysteine infusion. On both the treated and untreated sides of the brain, a significant de cline in postischemic CBF was observed during the final 20 min of reperfusion.
DISCUSSION
The present study demonstrated that local infu sion of L-homocysteine thiolactone in the brain (a) decreased basal CBF and ISF adenosine; (b) atten uated the increase in ISF adenosine during ischemia and early reperfusion; and (c) decreased the hyper emic response during reperfusion. We attribute the decrease in ISF adenosine observed with homocys teine to an increased adenosine consumption through condensation of adenosine with homocys teine delivered to the brain via the microdialysis probe. Homocysteine presumably diffuses across the cell membrane and into the cytosol, where it becomes available as a substrate for SAH forma tion. As SAH is not further metabolized (Ueland, 1982) and does not cross cell membranes (Walker and Duerre, 1974) , homocysteine effectively serves as a trapping agent for free intracellular adenosine.
Our data are consistent with reports in the liter ature that describe homocysteine-induced de creases in endogenous adenosine associated with increases in SAH. Schrader et ai. (1981) and Ach terberg et ai. (1985) report a slight attenuation in myocardial adenosine and a small increase in SAH with homocysteine in the normoxic isolated per fused heart; this response was more pronounced during hypoxia/ischemia. Tissue SAH accumula tion in the presence of elevated levels of homocys teine has been reported in the heart during acceler ated endogenous adenosine production or when adenosine is coadministered with homocysteine (Heinrichs et aI., 1986; Deussen et aI., 1988a,b) . SAH accumulation has also been reported in mouse brain after treatment with homocysteine alone or in combination with adenosine (Gharib et aI., 1983; Reddington and Pusch, 1983) . However, all these studies have involved quantitation of total tissue adenosine, making it difficult to determine the ef fect of homocysteine on the concentration of extra cellular and potentially vasoactive adenosine. Us- ing microdialysis to estimate ISF concentrations, the present study demonstrates that extracellular adenosine, inosine, and hypoxanthine are de creased during control conditions with local homo cysteine infusion. In contrast, with the exception of an attenuation of inosine and hypoxanthine accu mulation during the first 10 min of ischemia, levels of these metabolites were, in general, similar on both sides of the brain throughout the remainder of ischemia and during reperfusion. It is possible that during ischemia, when there is a net high-energy phosphate degradation, dephosphorylation of ino sine monophosphate (IMP) contributes to the ino sine pool.
To the best of our knowledge, these data are the first report of homocysteine-induced decreases in CBF. The decrease in CBF observed with homo cysteine is consistent with the known vasodilator properties of adenosine (Morii et aI. , 1986; McBean et aI., 1988; Van Wylen et aI. , 1989) . The 23% re duction in resting CBF concomitant with decreased adenosine is consistent with other reports that sug gest that adenosine contributes to resting cerebro vascular tone (Morii et aI. , 1987; Phillis and De Long, 1987; Pinard et aI. , 1989) . In addition, the attenuation of reactive hyperemia during early reperfusion on the side of homocysteine suggests J Cereb Blood Flow Metab, Vol. /3, No. 2, 1993 that the ischemia-induced increase in ISF adenosine plays a role in the hyperemic response following ischemia. Our data are in agreement with Seida et al. (1988) , who report that adenosine receptor blockade with aminophylline reduces the reactive hyperemia following ischemia .
Our data are also consistent with the known be havioral responses to homocysteine. Intraperitone al administration or local application of homocys teine has been shown to increase neuronal activity at low concentrations and produce dose-related convulsive seizures at higher concentrations (Blen now et aI., 1979; Folbergrova, 1974; Wuerthele et aI. , 1982; Dewhurst et aI. , 1983) . Adenosine is known to inhibit excitatory neurotransmitter re lease (Dunwiddie, 1985) , and has been proposed to serve as an endogenous anticonvulsant (Lee et aI. , 1984; Dragunow et aI., 1985) . Marangos et al. (1990) have recently demonstrated that homocysteine induced seizures are reversed by 5'-N-ethylcarbo ximide adenosine, an adenosine analogue, and by the purine precursor 5-amino-4-imidazole car boximide riboside. These and our data are consis tent with the idea that the convulsant actions of homocysteine are the result of adenosine sequestra tion and the subsequent effects on the balance of excitatory and inhibitory neurotransmitters.
In summary, under basal conditions and in re sponse to ischemia, local infusion of homocysteine decreased ISF adenosine coincident with an atten uation of CBF. The results of this study suggest that L-homocysteine uncouples the production of aden osine from its accum1llation in the extracellular space and, in doing so, can affect the vasoactive responses otherwise associated with increases in ISF adenosine.
